(Q36053847)

11 August 2017

Acarbose is an effective adjunct to dietary therapy in the treatment of hypertriglyceridaemias (English)

1 reference

11 August 2017

M Malaguarnera

1

1 reference

11 August 2017

I Giugno

2

1 reference

11 August 2017

P Ruello

3

1 reference

11 August 2017

M Rizzo

4

1 reference

11 August 2017

M Motta

5

1 reference

11 August 2017

G Mazzoleni

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

48

1 reference

11 August 2017

4

1 reference

11 August 2017

605-609

1 reference

Beneficial effects of acarbose on familiar hypertriglyceridemias.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

PROTECT interim results: a large multicenter study of patients with type II diabetes. Precose Resolution of Optimal Titration to Enhance Current Therapies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

The mechanism of alpha-glucosidase inhibition in the management of diabetes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

Classification of hyperlipidaemias and hyperlipoproteinaemias

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

Effects of fibrates on serum lipids and atherosclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: Dose-time-response relationships in man

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

Cholesterol determination in high-density lipoproteins separated by three different methods

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

Beneficial effects on serum lipids in noninsulin dependent diabetics by acarbose treatment

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014369

Plasma triglyceride response to carbohydrates, fats and caloric intake

11 July 2018

1 reference

12 December 2020

[Enzymatic determination of total cholesterol in serum (author's transl)]

1 reference

12 December 2020

Glucosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia

1 reference

12 December 2020

Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor

1 reference

12 December 2020

Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421)

1 reference

12 December 2020

Changes in plasma lipoprotein levels during medication with a glucoside-hydrolase inhibitor (acarbose)

1 reference

12 December 2020

Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man

1 reference

12 December 2020

Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions

1 reference

12 December 2020

Abnormal regulation of LDL receptor activity and abnormal cellular metabolism of hypertriglyceridaemic low density lipoprotein: normalization with bezafibrate therapy

1 reference

12 December 2020

10.1046/J.1365-2125.1999.00038.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

10583032

1 reference